Skip to main content
. 2020 May 15;12(5):2041–2051.

Table 2.

Performance of markers to distinguish (HCt+BPH) vs PCa

Markers AUC (p-value) IC 95% Sensitivity % Specificity % PPV % NPV %
PSA 0.922 (<0.001) 0.841-1.004 91.7 73.7 81.5 87.5
miR-107 0.523 (0.797) 0.347-0.699 95.8 5.3 56.1 50.0
miR-142-3p 0.706 (0.022) 0.536-0.876 100 0 55.8 0.0
miR-142-5p 0.652 (0.089) 0.483-0.822 100 0 55.8 0.0
miR-223-3p 0.684 (0.040) 0.518-0.851 83.3 52.6 69.0 71.4
miR-30a-5p 0.584 (0.346) 0.408-0.761 95.8 15.8 59.0 75.0
miR-30d-5p 0.757 (0.004) 0.605-0.908 83.3 68.4 76.9 76.5
miR-342-3p 0.626 (0.160) 0.456-0.797 70.8 52.6 65.4 58.8
miR-93-5p 0.741 (0.007) 0.594-0.888 79.2 52.6 67.9 66.7
Combined miRNA-model (142-3p+223-3p+30d-5p+93-5p) 0.836 (0.001) 0.718-0.953 79.2 57.9 70.4 68.8
Combined PSA_miRNA-model (PSA+142-3p+223-3p+93-5p) 0.963 (0.001) 0.898-1.028 100 89.5 92.3 100

Statistically significant AUC values (p≤0.05) are depicted in bold.